微小内镜下括约肌切开联合乳头球囊扩张与内镜下括约肌切开治疗胆总管结石(MARBLE试验):多中心随机对照试验研究方案
MARBLE试验为多中心、随机、开放标签、平行组研究,拟纳入18岁及以上需内镜下取石的胆总管结石患者,按1:1随机分入ESBD组(先行微小括约肌切开再行球囊扩张取石)或EST组(行超过 hooding fold 的中等切口后取石)。主要终点为操作相关不良事件(胰腺炎、出血、穿孔)发生率,次要终点包括技术成功率、临床成功率、操作时间、需碎石情况与结石复发率。
要点
- ESBD组先行微小括约肌切开,再行乳头球囊扩张后取石。
- EST组行超过 hooding fold 的中等切口后取石。
- 主要终点为操作相关不良事件发生率,含胰腺炎、出血、穿孔。
核心结论
- 本研究为首项多中心随机对照试验,前瞻性评估ESBD治疗小胆总管结石的疗效与安全性。
- 研究结果预期可判定ESBD相较传统EST能否成为新的标准治疗选择。
研究设计与样本
- 多中心、随机、开放标签、平行组试验;结局评估者不设盲,但采用预设客观标准以减少偏倚。
- 纳入18岁及以上、经影像学确诊需内镜下取石的胆总管结石患者,按1:1随机分入ESBD组或EST组。
主要发现
- 原文为研究方案,尚未报告试验结果。
关键数值与推荐
- ESBD组:先行微小括约肌切开,再行球囊扩张后取石。
- EST组:行超过 hooding fold 的中等切口后取石。
- 主要终点为操作相关不良事件发生率,包括胰腺炎、出血和穿孔。
- 次要终点包括技术成功率、临床成功率、操作时间、需碎石情况和结石复发率。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The first-line treatment for common bile duct stones (CBDS) is endoscopic transpapillary stone removal, typically performed using either endoscopic sphincterotomy (EST) or endoscopic papillary balloon dilation (EPBD). However, EST is associated with risks of bleeding and perforation, while EPBD carries a significant risk of post-procedural pancreatitis. Recently, a combined approach involving minimal EST followed by EPBD (ESBD) has been reported to mitigate these drawbacks, offering potentially safer and more effective outcomes. Nevertheless, no prospective study has adequately evaluated the utility of ESBD, as prior studies were mainly observational or limited by small sample sizes. Therefore, we designed a randomized controlled trial to investigate whether ESBD is superior to EST for the treatment of small CBDS. METHODS: This study is a multicenter, randomized, open-label, parallel-group trial; outcome assessors will not be blinded, but objective predefined criteria will be used to minimize bias. Eligible participants will include patients aged 18 years or older diagnosed with CBDS who require endoscopic stone removal, with eligibility confirmed via imaging modalities. After confirming eligibility, patients will be randomly assigned in a 1:1 ratio to either the ESBD group or the EST group. In the ESBD group, a minimal sphincterotomy will first be performed, followed by balloon dilation for stone extraction. In the EST group, a medium incision extending beyond the hooding fold will be performed prior to stone extraction. The primary endpoint is the incidence of procedure-related adverse events, including pancreatitis, bleeding, and perforation. Secondary endpoints include technical success rate, clinical success rate, procedure time, need for lithotripsy, and stone recurrence rate. DISCUSSION: This study is the first multicenter, randomized controlled trial to prospectively evaluate the efficacy and safety of ESBD for the treatment of small CBDS. The findings are expected to determine whether ESBD can serve as a new standard therapeutic option compared with conventional EST. TRIAL REGISTRATION: Japan Registry of Clinical Trials: jRCT1040250008. Registered on 21 April 2025. ( https://jrct.mhlw.go.jp/en-latest-detail/jRCT1040250008 ).
引用
- Inoue T, Maruta A, Kaneko J, et al. Minimal endoscopic sphincterotomy with papillary balloon dilation versus endoscopic sphincterotomy for the treatment of common bile duct stones (MARBLE Trial): study protocol for a multicenter randomized controlled trial. Trials. 2025. PMID: 40859328. doi:10.1186/s13063-025-09076-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。